IGC Pharma (IGC) Enterprise Value (2010 - 2026)
IGC Pharma (IGC) posted quarterly Enterprise Value of -$263000.0 for Q1 2026, up 35.06% year-over-year from -$194725.8 in Q1 2025, and up 73.05% quarter-over-quarter from -$976000.0 in Q4 2025.
IGC Pharma (IGC) Enterprise Value (2010 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Enterprise Value for 17 consecutive years, with -$263000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 35.06% year-over-year to -$263000.0; the TTM figure through Mar 2026 stood at -$263000.0 (up 35.06% YoY), while the FY2026 annual figure was -$263000.0, up 35.06% from the prior year.
- Enterprise Value advanced to -$263000.0 in Q1 2026 per IGC's latest filing, from -$976000.0 in the prior quarter.
- Across five years, Enterprise Value topped out at -$263000.0 in Q1 2026 and bottomed at -$10.5 million in Q1 2022.
- Historically, Enterprise Value has averaged -$2.9 million across 5 years, with a median of -$1.5 million in 2024.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 75.79% — and 2025, when it sank 107.66%.
- IGC Pharma's Enterprise Value stood at -$5.0 million in 2022, then surged by 72.62% to -$1.4 million in 2023, then jumped by 65.89% to -$470000.0 in 2024, then plunged by 107.66% to -$976000.0 in 2025, then soared by 73.05% to -$263000.0 in 2026.
- Business Quant data shows IGC's Enterprise Value at -$263000.0 in Q1 2026, -$976000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | -263,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -263,000.00 |
| Dec 31, 2025 | -976,000.00 |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -454,000.00 |
| Mar 31, 2025 | -405,000.00 |
| Dec 31, 2024 | -470,000.00 |
| Sep 30, 2024 | -1.55 Mn |
| Jun 30, 2024 | -1.82 Mn |
| Mar 31, 2024 | -1.20 Mn |
| Dec 31, 2023 | -1.38 Mn |
| Sep 30, 2023 | -3.22 Mn |
| Jun 30, 2023 | -1.95 Mn |
| Mar 31, 2023 | -3.50 Mn |
| Dec 31, 2022 | -5.03 Mn |
| Sep 30, 2022 | -6.82 Mn |
| Jun 30, 2022 | -8.05 Mn |
| Mar 31, 2022 | -10.46 Mn |
| Dec 31, 2021 | -11.94 Mn |
| Sep 30, 2021 | -14.40 Mn |
| Jun 30, 2021 | -13.32 Mn |